UBS has revised its rating on Ambev (ABEV, Financial), shifting it from Buy to Neutral. This change comes after the company's shares experienced a 20% increase in value since the start of the year. The new price target set by UBS is R$16.
The adjustment in Ambev's rating reflects a reassessment of the stock's current position, where the risk-reward balance appears more even. UBS analysts believe that at these levels, the potential for significant gains is tempered by existing market conditions and the stock's recent performance.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 8 analysts, the average target price for Ambev SA (ABEV, Financial) is $2.89 with a high estimate of $5.00 and a low estimate of $1.90. The average target implies an upside of 20.39% from the current price of $2.40. More detailed estimate data can be found on the Ambev SA (ABEV) Forecast page.
Based on the consensus recommendation from 9 brokerage firms, Ambev SA's (ABEV, Financial) average brokerage recommendation is currently 2.7, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Ambev SA (ABEV, Financial) in one year is $2.47, suggesting a upside of 2.92% from the current price of $2.4. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Ambev SA (ABEV) Summary page.
